Protagonist Therapeutics
PTGX
#2685
Rank
ยฃ4.82 B
Marketcap
ยฃ75.08
Share price
2.55%
Change (1 day)
116.15%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2026 (TTM): ยฃ55.63 Million

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ55.11 Million. In 2025 the company made a revenue of ยฃ34.16 Million a decrease over the revenue in the year 2024 that were of ยฃ0.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ55.63 M62.81%
2025 ยฃ34.16 M-90.13%
2024 ยฃ0.34 B635.07%
2023 ยฃ47.09 M114.35%
2022 ยฃ21.97 M8.41%
2021 ยฃ20.26 M-3.5%
2020 ยฃ21 M11822.44%
2019 ยฃ0.17 M-99.28%
2018 ยฃ24.36 M64.11%
2017 ยฃ14.84 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA